Telemedicine gained prominence during the pandemic's height. Two companies benefiting from the increased adoption of the technology are Teladoc Health (NYSE: TDOC) and Doximity (NYSE: DOCS). However, there are some important differences between these two corporations. The latter isn't exactly a pure-play telehealth company. Doximity is an online networking platform for medical professionals that provides telemedicine services, among others.

Still, Teladoc and Doximity should benefit from the increased adoption of telehealth in the coming years, so they might be decent stocks to consider for investors looking to cash in on it, too. But which one is the better buy?

There is much to like about Teladoc's business. The company is a leader in telehealth and facilitates millions of telemedicine visits every month. In the first quarter, Teladoc's total visits came in at 4.9 million, 8% higher than the year-ago period. The company's integrated care unit, where it offers a range of generalist and specialist virtual medical care, ended the period with 84.9 million paying U.S. members, an increase of 7% year over year.

Continue reading

Source Fool.com